Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Eli Lilly and Company
  6. Company
    LLY   US5324571083

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Eli Lilly and Company
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.

Number of employees : 35 000 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products22,320100%24,540100% +9.95%
Sales per region
2020
USD (in Million)%
United States14,22958%
Europe4,18817.1%
Japan2,58310.5%
Other Foreign Countries2,4239.9%
China1,1174.6%
Managers
NameAgeSinceTitle
David Ricks522017Chairman, President & Chief Executive Officer
Anat Ashkenazi472021Chief Financial Officer & Senior Vice President
Timothy Garnett-1998Chief Medical Officer & VP-Global Medical
Daniel Skovronsky46-Chief Scientific Officer & Senior Vice President
Diogo Rau-2021Senior VP, Chief Information & Digital Officer
Melissa Barnes512013Senior VP, Chief Ethics & Compliance Officer
Jon Erik Fyrwald612005Independent Director
Michael L. Eskew702008Independent Director
Ralph Alvarez652009Independent Director
Katherine Baicker, Dr.482011Independent Director
Members of the board
NameAgeSinceTitle
David Ricks522017Chairman, President & Chief Executive Officer
Jon Erik Fyrwald612005Independent Director
Michael L. Eskew702008Independent Director
Ralph Alvarez652009Independent Director
Katherine Baicker, Dr.482011Independent Director
William G. Kaelin, Dr.622012Independent Director
Marschall S. Runge, Dr.652013Independent Director
Jackson Peter Tai692013Independent Director
Juan Luciano582019Lead Independent Director
Jamere Jackson512016Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 959,488,446 957,560,051 99.8% 463,000 0.0% 99.8%
Shareholders
NameEquities%
Lilly Endowment, Inc. 109,412,100 11.4%
Capital Research & Management Co. 109,033,091 11.4%
The Vanguard Group, Inc. 65,660,721 6.85%
The PNC Financial Services Group, Inc. 52,012,151 5.42%
PNC Bank, NA (Investment Management) 51,595,739 5.38%
PRIMECAP Management Co. 35,378,235 3.69%
SSgA Funds Management, Inc. 32,506,101 3.39%
Wellington Management Co. LLP 31,788,979 3.31%
Fidelity Management & Research Co. LLC 28,521,589 2.97%
T. Rowe Price Associates, Inc. (Investment Management) 26,155,001 2.73%
Holdings
NameEquities%Valuation
Dicerna Pharmaceuticals, Inc. (DRNA) 5,414,1857.04%176,502,431 USD
Immunocore Holdings Plc 2,548,1456.25%104,473,945 USD
Avidity Biosciences, Inc. (RNA) 2,319,3966.17%55,062,461 USD
Precision BioSciences, Inc. (DTIL) 3,762,1906.55%39,615,861 USD
Sigilon Therapeutics, Inc. (SGTX) 2,744,4438.70%32,027,650 USD
NextCure, Inc. (NXTC) 2,088,8597.57%16,397,543 USD
Leap Therapeutics, Inc. (LPTX) 1,819,7583.05%2,948,008 USD
AC Immune SA (ACIU) 00.0000%
Markets and indexes
-
- International Market
- S&P 100 / S&P 500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  LILY11B:BZ
- Reuters Code :  
- Datastream Code :  
Company contact information
Eli Lilly and Company
Lilly Corporate Center
IN 46285 Indianapolis, Indiana


Phone : +1 617-225-3226
Fax :
web site : https://investor.lilly.com/
Brand Portfolio
In partnership withAllbrands.markets
More brands of Eli Lilly and Company
Analysis
U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big day" for patients
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Sector Other Pharmaceuticals
1st jan.Capitalization (M$)
ELI LILLY AND COMPANY28.58%197 349
JOHNSON & JOHNSON3.34%428 269
ROCHE HOLDING AG10.19%321 632
PFIZER, INC.6.09%218 590
NOVARTIS AG1.55%207 926
ABBVIE INC.6.39%201 349
MERCK & CO., INC.-7.60%191 373
NOVO NORDISK A/S19.63%188 238
ASTRAZENECA PLC13.63%152 565
BRISTOL-MYERS SQUIBB COMPANY5.21%145 715
AMGEN INC.3.82%137 152
SANOFI10.70%130 154
GLAXOSMITHKLINE PLC5.01%98 474
JIANGSU HENGRUI MEDICINE CO., LTD.-23.40%70 007
CHUGAI PHARMACEUTICAL CO., LTD.-20.97%64 499
ALLERGAN PLC0.97%63 659
BAYER AG4.97%59 319
TAKEDA PHARMACEUTICAL COMPANY LIMITED-0.59%52 707
DAIICHI SANKYO COMPANY, LIMITED-29.97%42 792
ASTELLAS PHARMA INC.24.78%33 250
EISAI CO., LTD.63.73%31 215
Connections : Eli Lilly and Company